Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation
Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to accurately investigate the efficacy of dronedarone in
maintaining sinus rhythm and decreasing AFB in patients with paroxysmal atrial fibrillation
as compared with placebo. This has never previously been performed using pacemaker Holter
monitoring which provides detailed information of atrial arrhythmia patterns the entire study
period. Additionally detailed patient symptom self assessment and questionnaires will be
collected. The study design will be double blinded crossover with each phase lasting 3
months.